These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 33161253)
21. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors. Wang NY; Xu Y; Xiao KJ; Zuo WQ; Zhu YX; Hu R; Wang WL; Shi YJ; Yu LT; Liu ZH Eur J Med Chem; 2020 Apr; 191():112152. PubMed ID: 32088495 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, biological evaluation and molecular docking study of novel thieno[3,2-d]pyrimidine derivatives as potent FAK inhibitors. Wang R; Yu S; Zhao X; Chen Y; Yang B; Wu T; Hao C; Zhao D; Cheng M Eur J Med Chem; 2020 Feb; 188():112024. PubMed ID: 31923858 [TBL] [Abstract][Full Text] [Related]
23. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents. Kamel MM; Megally Abdo NY Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148 [TBL] [Abstract][Full Text] [Related]
24. Discovery of new thieno[3,2-d]pyrimidine derivatives targeting EGFR Chen Y; Yang L; Qiao H; Cheng Z; Xie J; Zhou W; Huang X; Jiang Y; Yu B; Zhao W Eur J Med Chem; 2020 Aug; 199():112388. PubMed ID: 32402937 [TBL] [Abstract][Full Text] [Related]
25. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of novel pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidin-5-one derivatives. El-Nassan HB Eur J Med Chem; 2011 Jun; 46(6):2031-6. PubMed ID: 21429629 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. Fares M; Abou-Seri SM; Abdel-Aziz HA; Abbas SE; Youssef MM; Eladwy RA Eur J Med Chem; 2014 Aug; 83():155-66. PubMed ID: 24956552 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives. Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838 [TBL] [Abstract][Full Text] [Related]
29. Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance. Wang B; Zhao B; Chen ZS; Pang LP; Zhao YD; Guo Q; Zhang XH; Liu Y; Liu GY; Hao-Zhang ; Zhang XY; Ma LY; Liu HM Eur J Med Chem; 2018 Jan; 143():1535-1542. PubMed ID: 29126726 [TBL] [Abstract][Full Text] [Related]
30. Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity. Adly ME; Gedawy EM; El-Malah AA; El-Telbany FA Anticancer Agents Med Chem; 2018; 18(5):747-756. PubMed ID: 29366427 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Elmetwally SA; Saied KF; Eissa IH; Elkaeed EB Bioorg Chem; 2019 Jul; 88():102944. PubMed ID: 31051400 [TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. Ye T; Han Y; Wang R; Yan P; Chen S; Hou Y; Zhao Y Bioorg Chem; 2020 Jun; 99():103796. PubMed ID: 32283346 [TBL] [Abstract][Full Text] [Related]
33. Design, Synthesis and Biological Evaluation of [1,2,4]Triazolo[1,5- Yu GX; Hu Y; Zhang WX; Tian XY; Zhang SY; Zhang Y; Yuan S; Song J Molecules; 2022 Aug; 27(15):. PubMed ID: 35956943 [TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and antitumor activity evaluation of trifluoromethyl-substituted pyrimidine derivatives. Liu L; Wang Z; Gao C; Dai H; Si X; Zhang Y; Meng Y; Zheng J; Ke Y; Liu H; Zhang Q Bioorg Med Chem Lett; 2021 Nov; 51():128268. PubMed ID: 34302974 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and anti-tumor activities of N'-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives. Lou J; Liu Z; Li Y; Zhou M; Zhang Z; Zheng S; Wang R; Li J Bioorg Med Chem Lett; 2011 Nov; 21(22):6662-6. PubMed ID: 21986587 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors. El-Adl K; El-Helby AA; Sakr H; Elwan A Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414 [TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors. Abd El-Mageed MMA; Eissa AAM; Farag AE; Osman EEA Bioorg Chem; 2021 Nov; 116():105336. PubMed ID: 34530235 [TBL] [Abstract][Full Text] [Related]
38. Synthesis of certain benzothieno[3,2-d]pyrimidine derivatives as a selective SIRT2 inhibitors. Khalil NA; Ahmed EM; Zaher AF; El-Zoghbi MS; Sobh EA Eur J Med Chem; 2020 Feb; 187():111926. PubMed ID: 31812033 [TBL] [Abstract][Full Text] [Related]
39. Discovery of Novel [1,2,4]Triazolo[1,5- Hu K; Luo Y; Miao P; Zhao L; Zhao B; Shi XJ; Liu HM J Med Chem; 2024 Sep; 67(18):16435-16454. PubMed ID: 39285177 [TBL] [Abstract][Full Text] [Related]